Artificial intelligence for detecting diabetic retinopathy from eye photos
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests an AI system that automatically detects signs of diabetic retinopathy from eye photos. It aims to see if the AI can accurately identify these signs to help with early detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a high-quality color photo of the back of your eye (retina).
- You must have a confirmed diagnosis of diabetic retinopathy from an eye doctor.
- Your retinal photo must be clear and of good quality (no blurriness or shadows).
- You must not have other eye diseases that could interfere with reading the photo.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an AI platform that checks for diabetic retinopathy, a common eye problem in people with diabetes. It aims to see if the AI can spot signs of damage early, so you can get treatment sooner.
This trial uses an artificial intelligence (AI) system to check for diabetic eye disease (retinopathy) during your regular doctor visit. It aims to detect problems early so you can get treatment sooner.
This trial uses an AI system to test if it can find early signs of diabetic eye disease (diabetic retinopathy) in people with diabetes. If you have diabetes but no known eye problems, the AI might help catch issues early.
This trial tests whether putting a special AI-powered eye camera in your doctor's office can help catch diabetes-related eye damage early, so you can keep your vision. You just take a picture of your eye during a regular visit, and the AI helps detect issues sooner.
This trial tests a new AI-powered, do-it-yourself screening system for diabetic retinopathy. It may help find early signs of eye disease in people who haven't had an eye exam in the past year.
This study is testing an artificial intelligence tool that can automatically detect signs of glaucoma in photos of the retina. It may help confirm that the AI can accurately identify glaucoma, which could lead to faster diagnosis and monitoring for patients.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.